<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: This study aimed to quantify the reduced life expectancy for six types of potentially preventable <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in the United States </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: A total of 1,579,310 patients diagnosed with <z:e sem="disease" ids="C0684249,C0242379" disease_type="Neoplastic Process" abbrv="">cancers of the lung</z:e>, colon and rectum, liver, breast, cervix, or prostate in 1992-2005 were identified from the Surveillance, Epidemiology, and End Results registries </plain></SENT>
<SENT sid="2" pm="."><plain>The lifetime survival functions for the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cohort and age-/sex-matched reference population were generated using a semiparametric extrapolation method with annual life tables </plain></SENT>
<SENT sid="3" pm="."><plain>The average expected years of life lost (EYLL) for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> were calculated by subtracting the estimated life expectancy of the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cohorts from that of the reference population </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: <z:hpo ids='HP_0002896'>Liver cancer</z:hpo> and <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e> had an average EYLL of over 13years, while the EYLL for <z:hpo ids='HP_0012125'>prostate cancer</z:hpo> was below 2years </plain></SENT>
<SENT sid="5" pm="."><plain>When considering the annual incidence in 2012, <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e> would cause the greatest subtotal of EYLL (3,116,000years) followed by female <z:hpo ids='HP_0003002'>breast cancer</z:hpo> (1,420,000years) and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (932,000years) </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION: The potential life years saved by successful prevention, in terms of EYLL since diagnosis, would be substantial for <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e>, <z:hpo ids='HP_0003002'>breast cancer</z:hpo>, and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>This work will inform prioritization of strategies for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> control to minimize the life expectancy loss </plain></SENT>
</text></document>